Senator Ron Johnson Challenges COVID Vaccine Efficacy and Safety, Citing Dennis Rancourt's Estimate of '17 Million Deaths,' Alleges Federal Health Agencies Cover-Up

"What I most object to is is that the conclusion that the the vaccine saved millions of lives, that there's no science that backs that up. I think most people conclude that, okay, very vulnerable populations, if it boosts their immunity, it might save some lives, but but millions, while at the same time completely denying vaccine injuries."

"And and they're now looking point in the study, for example, that that mathematician, Dennis Rancourt from Canada, takes a look at and said, no. The vaccine probably caused 17 million deaths. And I don't know what the figure is."

"What I do know what I do know is our federal health agencies have completely covered up the fact that they knew they well knew about vaccine injuries. They knew about myocarditis. They knew about this within months, and they literally to this day have still done nothing about it."

"They just continue to cover up and continue to push what I would consider a very a very dangerous mRNA injection. It's not a vaccine. It's an injection. It it literally turns your body and its cells into a manufacturing site for something that is toxic to the body that the body attacks."

"When the body attacks something, it creates inflammation. That's what myocarditis is. That's, you know, attacks the the the spinal column and and nerves. That's what all these neurological symptoms are."

"And now now we know that it has DNA contamination, including the the SV40 sequence, cancer causing. We're hearing about these terrible cancers. You know, we hear about them, but, you know, the the rest of the media is completely completely covering it up. And, again, the the federal health agencies are covering up as well."

https://x.com/newstart_2024/status/1883951597278867631

Full vid: COVID: The Biggest Government Cover-Up In History? - https://www.youtube.com/watch?v=MA3XqkQRPXc&t=41s

>>22447284

First Lady Melania Trump’s Official White House Portrait

https://x.com/FLOTUS/status/1883975986683007036

>>22447005

Questions Raised on Pre-COVID Vaccine Plans and Media Influence

Jillian Michaels and Senator Ron Johnson have brought attention to a pre-COVID initiative aimed at expanding vaccination globally, beyond the usual childhood vaccines in the U.S.

Jillian Michaels: "Pre-COVID, you've got me with a plan to have a universal vaccine program. So this is beyond the childhood vaccine schedule that exists here in America. This is like, 'We gotta vaccinate the planet.'"

"We have the Trusted News Initiative? I've never even what is that? I've never even heard of that."

Senator Ron Johnson: "That is something, they all they all got together."

Johnson further reveals the chilling coordination among media outlets, where local news anchors parrot the same script: "The sharing of biased and false news has become all too common on social media," to control what people think, thus endangering democracy itself.

The plot thickens when Johnson notes, "They've done this in plain sight. Yep. You know, they'll hold these conferences. They'll videotape them. They they're there." He points to the Milken Institute where Rick Bright and Fauci advocate for this universal vaccine program.

The pharmaceutical industry's dark side is exposed when Johnson discusses Novartis, "they're pretty excited about maybe having a drug that could end this thing. All of a sudden, they go dark." Why? Because, "therapeutics treating this need not apply" — an admission that effective alternatives like ivermectin, hydroxychloroquine, budesonide, or corticosteroids would tank the emergency use authorization of an untested injection.

Senator Ron Johnson: "They couldn't have moved it through the emergency use prep act, right, if you had a working therapeutic like ivermectin, for example."

This scathing exposé raises serious questions about media control, pharmaceutical agendas, and the integrity of public health policy. The narrative pushed by those in power is not just about health; it's about control.

https://x.com/newstart_2024/status/1883982034990948428

>>22447444

this is extremely dangerous to our democracy@ 1:03

DeepSeek on SV40 promoters.

The very first thing it highlights is Oncogenic potential!

When will @TGAgovau and @US_FDA get current on molecular biology?

@BroadbentMP @SenatorRennick @SenRonJohnson @JesslovesMJK @DJSpeicher @Double_Christ @MendenhallFirm

Prompt- What are the hazards associated with injection 50-500B SV40 promoters wrapped in LNPs?

DeepSeek-

Injecting SV40 promoters wrapped in lipid nanoparticles (LNPs) into a biological system, such as the human body, carries several potential hazards and risks. Here are some key concerns:

### 1. Oncogenic Potential:

• SV40 Promoter: The SV40 (Simian Virus 40) promoter is a strong viral promoter often used in molecular biology to drive high levels of gene expression. However, SV40 has been associated with oncogenic (cancer-causing) properties in certain contexts. The promoter itself can potentially integrate into the host genome and disrupt normal gene regulation, leading to uncontrolled cell proliferation and cancer.

### 2. Immune Response:

• Immune Activation: The introduction of foreign genetic material, especially viral promoters like SV40, can trigger an immune response. This could lead to inflammation, autoimmune reactions, or other adverse immune responses.

• LNP Immunogenicity: Lipid nanoparticles (LNPs) themselves can be immunogenic, potentially causing an inflammatory response or other immune-related side effects.

### 3. Genomic Integration and Mutagenesis:

• Insertional Mutagenesis: If the SV40 promoter integrates into the host genome, it could disrupt essential genes or regulatory elements, leading to mutations that might cause disease, including cancer.

• Off-Target Effects: The SV40 promoter might drive expression of genes in unintended tissues or cell types, leading to off-target effects and potential toxicity.

### 4. Toxicity and Cellular Stress:

• Cellular Stress: High levels of gene expression driven by the SV40 promoter could overwhelm cellular machinery, leading to cellular stress, apoptosis (programmed cell death), or necrosis.

• LNP Toxicity: While LNPs are generally considered safe, high doses or repeated administration could lead to toxicity, including liver damage or other organ-specific toxicity.

### 5. Biodistribution and Off-Target Effects:

• Biodistribution: LNPs can distribute to various tissues beyond the intended target, potentially leading to expression of the SV40 promoter in unintended locations, which could have unpredictable effects.

• Off-Target Gene Expression: The SV40 promoter might drive expression of genes in non-target tissues, leading to unintended biological effects or toxicity.

### 6. Long-Term Effects:

• Persistence: If the SV40 promoter persists in the body, it could lead to long-term expression of genes, which might be undesirable or harmful over time.

• Latent Effects: There could be latent effects that only become apparent after a long period, such as delayed immune responses or late-onset oncogenesis.

### 7. Ethical and Regulatory Concerns:

• Ethical Considerations: The use of viral promoters in humans raises ethical concerns, especially given the potential for long-term and unpredictable effects.

• Regulatory Hurdles: Regulatory agencies may have stringent requirements for the use of viral promoters in therapeutic contexts, given the associated risks.

### 8. Environmental and Horizontal Gene Transfer Risks:

• Environmental Release: If the LNPs containing SV40 promoters are released into the environment, there is a risk of horizontal gene transfer to other organisms, potentially leading to unintended ecological consequences.

### Conclusion:

The use of SV40 promoters wrapped in LNPs carries significant risks, including potential oncogenicity, immune activation, genomic instability, and off-target effects. These risks must be carefully weighed against the potential benefits, and thorough preclinical and clinical testing would be required to ensure safety. Regulatory oversight and ethical considerations are also critical in the development and application of such technologies.

https://x.com/Kevin_McKernan/status/1883944035221434417

>>22447670

kek

### 1. Oncogenic Potential:

• SV40 Promoter: The SV40 (Simian Virus 40) promoter is a strong viral promoter often used in molecular biology to drive high levels of gene expression. However, SV40 has been associated with oncogenic (cancer-causing) properties in certain contexts. The promoter itself can potentially integrate into the host genome and disrupt normal gene regulation, leading to uncontrolled cell proliferation and cancer.

### 2. Immune Response:

• Immune Activation: The introduction of foreign genetic material, especially viral promoters like SV40, can trigger an immune response. This could lead to inflammation, autoimmune reactions, or other adverse immune responses.

• LNP Immunogenicity: Lipid nanoparticles (LNPs) themselves can be immunogenic, potentially causing an inflammatory response or other immune-related side effects.

### 3. Genomic Integration and Mutagenesis:

• Insertional Mutagenesis: If the SV40 promoter integrates into the host genome, it could disrupt essential genes or regulatory elements, leading to mutations that might cause disease, including cancer.

• Off-Target Effects: The SV40 promoter might drive expression of genes in unintended tissues or cell types, leading to off-target effects and potential toxicity.

### 4. Toxicity and Cellular Stress:

• Cellular Stress: High levels of gene expression driven by the SV40 promoter could overwhelm cellular machinery, leading to cellular stress, apoptosis (programmed cell death), or necrosis.

• LNP Toxicity: While LNPs are generally considered safe, high doses or repeated administration could lead to toxicity, including liver damage or other organ-specific toxicity.

### 5. Biodistribution and Off-Target Effects:

• Biodistribution: LNPs can distribute to various tissues beyond the intended target, potentially leading to expression of the SV40 promoter in unintended locations, which could have unpredictable effects.

• Off-Target Gene Expression: The SV40 promoter might drive expression of genes in non-target tissues, leading to unintended biological effects or toxicity.

### 6. Long-Term Effects:

• Persistence: If the SV40 promoter persists in the body, it could lead to long-term expression of genes, which might be undesirable or harmful over time.

• Latent Effects: There could be latent effects that only become apparent after a long period, such as delayed immune responses or late-onset oncogenesis.

### 7. Ethical and Regulatory Concerns:

• Ethical Considerations: The use of viral promoters in humans raises ethical concerns, especially given the potential for long-term and unpredictable effects.

• Regulatory Hurdles: Regulatory agencies may have stringent requirements for the use of viral promoters in therapeutic contexts, given the associated risks.

### 8. Environmental and Horizontal Gene Transfer Risks:

• Environmental Release: If the LNPs containing SV40 promoters are released into the environment, there is a risk of horizontal gene transfer to other organisms, potentially leading to unintended ecological consequences.

### Conclusion:

The use of SV40 promoters wrapped in LNPs carries significant risks, including potential oncogenicity, immune activation, genomic instability, and off-target effects. These risks must be carefully weighed against the potential benefits, and thorough preclinical and clinical testing would be required to ensure safety. Regulatory oversight and ethical considerations are also critical in the development and application of such technologies.